Peter Biotherapeutics
Pre-clinicalPeterBio is a Boston based biotech company that has developed a breakthrough gene-editing technology called RITDM that does not require DNA cleavage.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
PeterBio is a Boston based biotech company that has developed a breakthrough gene-editing technology called RITDM that does not require DNA cleavage.
BiologicsImmunologyAntibodies